ADHD pharmacotherapy and mortality in individuals with ADHD
JAMA
About The Study: In this observational, target trial emulation analysis that included 148,000 individuals diagnosed with attention-deficit/hyperactivity disorder (ADHD) in Sweden, initial dispensation of ADHD medication was significantly associated with lower all-cause and unnatural-cause mortality, whereas the association with natural-cause mortality was not significant.
Authors: Zheng Chang, Ph.D., and Lin Li, Ph.D., of the Karolinska Institutet in Stockholm, are the corresponding authors.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.0851)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.0851?guestAccessKey=6cde62e2-a014-4f81-8995-2bcc552ecade&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031224
END
Authors: Zheng Chang, Ph.D., and Lin Li, Ph.D., of the Karolinska Institutet in Stockholm, are the corresponding authors.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jama.2024.0851)
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
# # #
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2024.0851?guestAccessKey=6cde62e2-a014-4f81-8995-2bcc552ecade&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031224
END